secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2024-03-22T23:59:59+00:00
Accession:  0001104659-24-037932
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq issues reprimand to First Wave BioPharma for shareholder approval lapse; matter closed
--------------------------------------------------------------------------------

- On March 19, 2024, Nasdaq issued a Letter of Reprimand for the July 2023 offering of 610k shares and warrants at $0.64/share.
- The offering was deemed not a public offering under Rule 5635(d) because one investor bought a predominant portion; shareholder approval was required but not obtained.
- The Company obtained shareholder ratification on December 12, 2023, as remedial action.
- Nasdaq noted the failure was inadvertent, no prior pattern of non-compliance, and considers the matter closed.
- No delisting or further sanctions imposed; the Company remains listed on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465924037932/0001104659-24-037932-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465924037932/tm249572d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-037932

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer